v3.24.3
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Expenses    
Research and development $ 252 $ 1,859
General and administrative 1,957 1,103
Operating expenses (2,209) (2,962)
Other income (loss)    
Foreign exchange (1) (2)
Interest, net 49 2
Other income (loss) 48 0
Net loss for the period (2,161) (2,962)
Computation of basic loss per share    
Net loss (2,161) (2,962)
Series A Preferred cash dividend (2) (2)
Series C Preferred stock dividend (13) (173)
Net loss for the period attributable to common stockholders $ (2,176) $ (3,137)
Basic and fully diluted loss per share $ (1.37) $ (63.92)
Basic and fully diluted weighted average number of shares 1,586,000 49,000

Source